Patricia S Campbell

Title: **Patricia S. Campbell: A Pioneer in Transdermal Drug Delivery Innovations**

Introduction

Patricia S. Campbell, based in Palo Alto, CA, is a notable inventor with an impressive portfolio of 24 patents. Her work primarily focuses on innovative formulations for the administration of drugs using transdermal delivery systems. With her contributions, she has significantly impacted the field of pharmaceutical technology, particularly in how medications can be effectively delivered through the skin.

Latest Patents

Campbell's latest patents showcase her expertise in drug formulations aimed at maximizing therapeutic effectiveness while minimizing side effects. One notable patent is titled "Formulations for the administration of fluoxetine." This invention pertains to a composition of matter designed for application to body surfaces or membranes to facilitate the transdermal delivery of fluoxetine. It emphasizes the use of permeation enhancers to improve the absorption rate while reducing skin irritation levels, particularly when fluoxetine acetate is co-administered with a corticosteroid like hydrocortisone.

Another significant contribution is her patent for "Formulations for transdermal delivery of pergolide." Similar to her fluoxetine formulation, this patent outlines a composition that enables pergolide administration through the skin, also utilizing permeation enhancers to enhance the delivery process. These inventions are complemented by the development of drug delivery devices that facilitate the transdermal administration of both fluoxetine and pergolide formulations.

Career Highlights

As a key figure at Alza Corporation, Patricia S. Campbell has devoted her career to advancing pharmaceutical technologies through innovative drug delivery systems. Her extensive research and development efforts have solidified her reputation as a leader in the realm of transdermal drug delivery.

Collaborations

Throughout her career, Campbell has collaborated with esteemed colleagues such as Su Il Yum and David J. Enscore. These partnerships have further enhanced her research and contributed to the successful development of her patents, fostering an environment of innovation and excellence within the pharmaceutical industry.

Conclusion

Patricia S. Campbell remains a pivotal inventor in the field of transdermal drug delivery, with her 24 patents reflecting a commitment to improving patient outcomes through innovative formulations. Her work continues to influence the future of pharmaceutical delivery methods, standing as a testament to the power of innovation in addressing complex medical challenges.